Profil
Zhi Hua Yu currently works at Betta Pharmaceuticals Co., Ltd., as Non-Executive Director from 2017 and Beijing Longpan Investment Management Consulting Center GP, as Chief Partner from 2010.
Mr. Yu also formerly worked at Jiangsu Yahong Meditech Co., Ltd., as Director from 2017 to 2023 and ImmuneOnco Biopharmaceuticals (Shanghai), Inc., as Non-Executive Director.
Mr. Yu received his graduate degree and Masters Business Admin degree from George Washington University and undergraduate degree from Renmin University of China.
Postes actifs de Zhi Hua Yu
| Sociétés | Poste | Début |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | 06/09/2017 |
Beijing Longpan Investment Management Consulting Center GP
Beijing Longpan Investment Management Consulting Center GP Investment ManagersFinance Acts as an alternative investment manager | Directeur Général | 23/08/2010 |
Anciens postes connus de Zhi Hua Yu
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Directeur/Membre du Conseil | 14/10/2024 |
| JIANGSU YAHONG MEDITECH CO., LTD. | Directeur/Membre du Conseil | 10/12/2023 |
Formation de Zhi Hua Yu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renmin University of China
Renmin University of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the discovery, development and commercialization of drugs | Health Technology |
Beijing Longpan Investment Management Consulting Center GP
Beijing Longpan Investment Management Consulting Center GP Investment ManagersFinance Acts as an alternative investment manager | Finance |
Jiangsu Yahong Meditech Co., Ltd.
Jiangsu Yahong Meditech Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and commercialization of medicines in the fields of urogenital system tumors and major diseases fields | Health Technology |
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products | Health Technology |
















